CD4 and irritable bowel syndrome: In our population of IBD patients, the mean frequency of CD25hiFOXP3+ cells among total CD4+ T cells was significantly increased in peripheral blood (PB) after anti-TNFα therapy compared to T0 (Figure 1), as assessed by t test for paired samples (P = 0.0009).